Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Supakorn Rojananin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Gland Surgery|September 11, 2014
International oncoplastic breast surgery trainingSupakorn Rojananin, Visnu Lohsiriwat
International Journal of Endocrinology|June 16, 2012
Primary hyperparathyroidism: 11-year experience in a single institute in ThailandPoramaporn Prasarttong-Osoth, Pakpong Wathanaoran, Waraporn Imruetaicharoenchoke, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 18, 2013
A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancerSuthinee Ithimakin, Adune Ratanawichitrasin, Vutisiri Veerasarn, et al.
Molecular Medicine Reports|August 2, 2013
Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressivenessDoonyapat Sa-Nguanraksa, Tuenjai Chuangsuwanich, Tawatchai Pongpruttipan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Gland Surgery|September 11, 2014
International oncoplastic breast surgery trainingSupakorn Rojananin, Visnu Lohsiriwat
International Journal of Endocrinology|June 16, 2012
Primary hyperparathyroidism: 11-year experience in a single institute in ThailandPoramaporn Prasarttong-Osoth, Pakpong Wathanaoran, Waraporn Imruetaicharoenchoke, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 18, 2013
A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancerSuthinee Ithimakin, Adune Ratanawichitrasin, Vutisiri Veerasarn, et al.
Molecular Medicine Reports|August 2, 2013
Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressivenessDoonyapat Sa-Nguanraksa, Tuenjai Chuangsuwanich, Tawatchai Pongpruttipan, et al.
Pageof 1